Speciality Medicine Limited
GST : 27ABFCS4085C1ZC

Call us now

07971891387( PIN:727)

Send Inquiry

Request To Call Back

Nivolumab 100 mg

Name: Nivolumab 100 mg
Brand: Speciality Medicine Limited

Get a Price/Quote

MOQ : 100 Units

Nivolumab 100 mg Specification

Indication
Treatment of various cancers such as metastatic melanoma, non-small cell lung cancer, renal cell carcinoma, and Hodgkin lymphoma

Dosage Form
Lyophilized powder for solution

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Imported/Indian (varies by brand)

Brand Name
Varies (e.g., Opdivo)

Life Span
24 months from manufacturing date

Packaging Type
Vial

Salt Composition
Nivolumab 100 mg

Drug Type
Biological

Ingredients
Nivolumab

Physical Form
Injection

Function
Immune checkpoint inhibitor for cancer therapy

Recommended For
Cancer Patients

Dosage
As directed by oncologist

Dosage Guidelines
Administered intravenously under medical supervision

Suitable For
Adults

Quantity
100 mg/vial

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Minimum Order Quantity
1 vial

Contraindications
Known hypersensitivity to Nivolumab or excipients

Shelf Life
24 months

Drug Category
Immunotherapy

Administration Route
Intravenous infusion

Approval Status
FDA & EMA approved for multiple indications

Reconstitution
Requires dilution with appropriate sterile solution before IV use

Side Effects
Fatigue, rash, pruritus, diarrhea, nausea, decreased appetite, immune-related adverse reactions

Therapeutic Area
Oncology

HSN Code
30043919

Usage
Only to be administered by healthcare professionals in a clinical setting

ATC Code
L01XC17

Prescription/Non-Prescription
Prescription

Color
White to off-white (lyophilized powder)

Patient Population
Adults and selected pediatric indications as per label

Nivolumab 100 mg Trade Information

Minimum Order Quantity
100 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Nivolumab 100 mg

Experience the popular and sizzling advancements in oncology care with Nivolumab 100 mg-an astounding immunotherapy approved by FDA & EMA for treating multiple cancers, including metastatic melanoma and non-small cell lung cancer. This world-class, gorgeous white to off-white lyophilized powder is supplied in vials and is suitable for intravenous infusion under expert medical supervision. Trusted for its efficacy as an immune checkpoint inhibitor, Nivolumab offers cancer patients hope and innovative treatment options. Add to Cart today for assured quality from leading exporters, suppliers, and traders in India. Minimum order: 1 vial.

Therapeutic Usage and Application Surface

Nivolumab 100 mg is an advanced immunotherapy administered exclusively by healthcare professionals to adult and certain pediatric cancer patients. Designed strictly for intravenous infusion, its application surface involves only clinical, supervised settings ensuring patient safety and optimal outcomes. The drug is indicated for multiple cancers such as melanoma, lung, kidney, and Hodgkin lymphoma. Usage is based on an oncologist's prescription and tailored to individual patient needs in accordance with approved cancer treatment protocols.

Packaging, Delivery, and Domestic Market Reach

Each Nivolumab 100 mg vial is meticulously packaged as a lyophilized powder in a single-unit box, ensuring product stability. Strong domestic market presence across India is supported by efficient logistics and streamlined transportation networks, guaranteeing timely delivery. Products are typically dispatched promptly, considering shelf-life and sensitive storage needs (refrigeration 2C-8C). Robust supply chains ensure seamless availability in hospitals and clinics nationwide, reinforcing the commitment to oncology care excellence in the Indian market.

FAQ's of Nivolumab 100 mg:

Q: How is Nivolumab 100 mg administered?

A: Nivolumab 100 mg is administered intravenously by trained healthcare professionals, typically in a hospital or clinical setting, after proper dilution with a sterile solution, as per oncologist's instructions.

Q: What cancers can be treated with Nivolumab 100 mg?

A: Nivolumab 100 mg is approved for treating various cancers, including metastatic melanoma, non-small cell lung cancer, renal cell carcinoma, and Hodgkin lymphoma.

Q: Where should Nivolumab 100 mg be stored?

A: Nivolumab should be stored in a refrigerator at temperatures between 2C and 8C. It must not be frozen and should remain in its original packaging until ready for use.

Q: What is the process for reconstituting Nivolumab 100 mg before use?

A: Before administration, Nivolumab 100 mg lyophilized powder requires reconstitution and dilution with an appropriate sterile solution following the specific preparation steps outlined by the manufacturer and healthcare guidelines.

Q: Who should use Nivolumab 100 mg injection?

A: Nivolumab 100 mg is recommended for use by adults and certain pediatric patients diagnosed with specific cancers and must always be administered under medical supervision.

Q: What are the potential side effects of Nivolumab 100 mg?

A: Common side effects include fatigue, rash, pruritus, diarrhea, nausea, decreased appetite, and immune-related adverse reactions. Patients should promptly report any unusual symptoms to their healthcare team.

Tell us about your requirement